LONDON, Feb. 28, 2017 /PRNewswire/ -- Manufacturing execution system market to exhibit significant growth potential between 2016 and 2022" The Manufacturing execution system (MES) market is expected ...

Legacy MES software was often inflexible and vendor-dependent, requiring massive upfront investments and making upgrades difficult, but modern MES offers modular ...

Stringent global regulations, the need for electronic batch records, and increasing focus on data integrity are pushing pharma manufacturers to adopt MES. Rapid growth in biologics, vaccines, and high ...

Last month I asked ChatGPT which benefits its integration with a manufacturing execution system (MES) could provide and what the role of a system integrator could be in such a scenario. It provided me ...

HORSHAM, Pa., CHANDLER, Ariz. & MEDIA, Pa.--(BUSINESS WIRE)--Aegis Software is showing leadership by supporting a global study on how to ensure AI and analytics deliver benefits to manufacturers. The ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As manufacturing companies digitally transform their operations, they must leverage smart ...

The monitoring and reporting demands on medical device manufacturing are already massive but managing them for multiple companies at once, as a contract manufacturer, adds even greater complexity.

There is now broad consensus that data-driven decision-making is essential to success in today’s highly competitive manufacturing environment. Customers’ price-consciousness, combined with demands for ...

Stéphane Donzé is the Founder and CEO of AODocs, with more than 20 years of experience in the enterprise content management industry. Manufacturing organizations invest heavily in product lifecycle ...

Automation in pharmaceutical manufacturing enhances efficiency, consistency, and quality, driven by drug complexity, cost pressures, and workforce challenges. Despite benefits, automation is ...

DELRAY BEACH, Fla, Dec. 15, 2025 /PRNewswire/ --According to MarketsandMarkets, the Pharmaceutical Manufacturing Execution System market is expected to grow to USD 4.62 billion by 2030 from USD 2.37 ...